p50α at the synapse of T cell/APC conjugates. In association with the p110 catalytic subunit, p50α is known to carry a stronger lipid kinase activity compared to p85α. Accordingly, we observed that ICOS engagement results in a stronger activation of PI3K. Together, these findings provide evidence that p50α is likely a determining factor in ICOS mediated PI3K activity in T cells. These results also suggest that a differential recruitment and activity of class IA PI3K subunits represents a novel mechanism in the control of PI3K signaling by costimulatory molecules.
Introduction

T lymphocyte activation is based on multiple and complex interactions between T cells and antigen presenting cells (APC).
It is now commonly accepted that optimal T cell activation requires several independent signals (1). The first one, which determines the specificity of the immune response, is delivered through the antigen receptor interaction with the MHC-antigen complex on the APC surface. An additional costimulatory signal is crucial for complete T cell activation which leads to cytokine production and cell proliferation. On T cells, the best characterized costimulatory molecule is CD28, but several other costimulatory molecules like the ICOS inducible costimulator have also been described (2, 3) . CD28 and ICOS (also known as CD278) deliver positive signals during T cell activation. They bind respectively to B7 molecules (B7.1/CD80 and B7.2/CD86) and ICOS ligand (ICOSL/CD275) expressed in various tissues, including APCs (4, 5) . These two costimulatory receptors have unique and overlapping functions that synergize to regulate CD4 + T cell differentiation (6) .
CD28 is expressed in resting and activated T cells, while ICOS expression is induced upon T cell activation. ICOS binds to a specific ligand, ICOSL, that is expressed on both lymphoid and non-lymphoid cells (4, 5). Recent studies indicated that the ICOS-ICOSL pathway plays
an important role in Th2 responses in asthma and allergies (7, 8) , Th1-Th2 responses during bacterial infections (9, 10) , tumor cell rejection and during the pathologic process of chronic graft rejection in vivo (11, 12) . ICOS mediated costimulation leads predominantly to the production of effector cytokines such as IL-4 and IL-10 and to a lesser extend in the production of IL-2, IFN-γ and TNF-α (4, 13, 14) .
In humans, signaling pathways induced by the costimulatory molecule ICOS remain poorly understood. ICOS bears a unique YXXM signaling motif in its intracellular tail that binds the p85α regulatory subunit of phosphoinositide 3-kinase (PI3K) (7, 15) . This is in contrast to CD28 that has several SH2 4 and SH3 binding motifs for proteins such as Grb2, GRID, Lck, Itk and Tec (16) . ICOS signaling has been shown to essentially involve the PI3K pathway since so far, p85α is the only identified signaling molecule that interacts with ICOS (17) . Although ICOS seems to be more limited in generating intracellular signals, ICOS stimulation in combination with TcR shows a much stronger capability to activate PI3K than CD28 (18, 19) . Class IA PI3K is composed of a p110 catalytic subunit (either the α, β or δ isoforms) and a regulatory subunit which can be p85α, p55α or p50α (encoded by the pik3r1gene), p85β (encoded by the pik3r2 gene) or p55γ (encoded by the pik3r3 gene) (20) .
p85α, p55α and p50α regulatory subunits share a common C-terminal region consisting of two SH2 domains flanking the p110 catalytic binding site and have a unique N-terminal region of 304, 34 and 6 amino acids respectively (21) .
Although it has been showed that p50α associated PI3K activity in response to insulin stimulation is greater than p85α or p55α (21) (22) (23) , little is known about their relative function and contribution during T cell activation. We therefore made the hypothesis that the difference in PI3K activity between ICOS and CD28 costimulation could be linked to a differential recruitment of the regulatory isoforms.
In this study, we show that the p50α PI3K regulatory subunit is recruited by costimulatory receptors only on activated T cells. Despite similar expression levels before and after cell activation, we also report that p50α accumulates at the immunological synapse (IS)
in activated but not in resting T cells. We show that ICOS may have a specific role in recruiting p50α at the membrane, as ICOS triggering induces p50α localization to the plasma membrane through its YMFM intracellular motif. Upon ICOS ligation, p50α associated PI3K activity is stronger than that associated with p85α. Finally ICOS but not CD28 ligation, induces a strong phosphorylation of Akt in activated T cells. Collectively, our results suggest that ICOS makes use of the p50α regulatory subunit to sustain PI3K activity in activated T cells.
Materials and Methods
Cells
Human CD4+ T cells and monocytes were isolated from healthy blood donors by Ficoll density gradient centrifugation followed by negative and positive depletion respectively on magnetic beads (CD4 + T Cell Isolation Kit II human, CD14 microbeads, Miltenyi respectively, BD Biosciences Pharmingen).
Statistical analysis
Statistical analysis was performed with the Wilcoxon-Mann-Whitney test using Cytel's StatXact® software. Values of p < 0.05 were considered significant.
Results
The p50α PI3K regulatory subunit is recruited by costimulatory receptors only on activated T cells.
Class IA PI3K members have been implicated in immune T cell signaling. However, little is known about the expression status of PI3K regulatory subunit isoforms in hematopoietic cell lines and in particular, in human T lymphocytes. Indeed, most studies involving PI3K signaling events focussed on p85α expression and function neglecting the participation of other PI3K regulatory subunits. In order to determine the expression pattern of class IA PI3K regulatory subunits in resting and activated human T cells, Western blot analyses of cell lysates with a polyclonal antiserum that recognizes all regulatory alpha subunits were performed (Fig. 1A) . In resting T cells, two bands corresponding to p85α and p50α were
detected. An additional 55kDa band corresponding to p55α, appeared in activated T cells.
Like the CD28 costimulatory receptor, ICOS, whose expression is induced following T cell activation (Fig. 1B) , is known to bind the p85α regulatory subunit. Upon CD28 or ICOS ligation, the binding of the different PI3K regulatory subunits to CD28 or ICOS was next investigated. As shown in Fig. 1C , (left panel), in resting T cells, p85α but not p50α is able to interact with CD28 following receptor triggering. In activated T cells, a slight constitutive association of p85α and p55α with ICOS and CD28 was observed. However, ICOS triggering (alone or in combination with CD3 antibody) led to the recruitment of p50α within the receptor. ICOS ligation also greatly enhanced its association with p85α compared to unstimulated or CD3+CD28 stimulated T cells (Fig. 1C, middle panel) . Thus, similar levels of p85α and p50α association to CD28 or ICOS were detected upon stimulation, but surprisingly, ICOS ligation promoted CD28 association "in trans" with the two regulatory subunit isoforms as efficiently as CD28 triggering (Fig. 1C, right panel) . These results demonstrate a selective recruitment of p50α to ICOS and CD28 receptors in activated T cells.
They also suggest that ICOS triggering strengthens CD28 interactions with class IA alpha regulatory subunits.
ICOS costimulation shows a stronger ability to activate PI3K than CD28 costimulation (19) . Using PI3K activity ELISA kit, we showed that ICOS ligation induces a higher PI3K activity in activated T cells compared to CD28 ligation (Fig. 1D) . As it has been previously reported that p50α and p85α are carrying distinct PI3K activities (21-23), these observations prompt us to investigate the dynamic of recruitment of these regulatory subunits at the plasma membrane of activated T cells.
The p50α regulatory subunit localizes at the immunological synapse on activated T lymphocytes.
The p85α and p50α regulatory subunits are derived by alternative splicing of the same gene pik3r1 (31) . These molecules share two SH2 domains, the p110-binding inter-SH2 domain and a proline-rich region. They differ in their N-terminal domain: p50α has a unique 6 aminoacid sequence and p85α has a specific Bcr homology domain (BH) and a SH3 domain. We used GFP fusion proteins of p85α and p50α ( Fig. 2A ) in order to visualize the recruitment of these regulatory subunits in T cell/APC conjugates. It is now commonly accepted that class IA PI3K regulatory subunits stabilize the unstable and labile p110 catalytic subunits (32) . To verify that our GFP-p50α and GFP-p85α constructs were functional, immunoprecipitation experiments were carried out in Jurkat T cells coexpressing a Myc-tagged form of the p110δ catalytic subunit and either GFP-p50α or GFP-p85α. Unlike the GFP molecule used in the control, both GFP-p50α and GFP-p85α constructs bind the co-transfected p110δ catalytic subunit molecule (Fig. 2B) . We next evaluated p85α and p50α recruitment to the immunological synapse in a system of T-DC conjugates by mixing SAg pulsed DCs with either resting T cells or activated T cells transfected with GFP-p50α or GFP-p85α constructs (Fig. 2C) . A similar GFP-p50α or GFP-p85α relocalization to the immunological synapse was observed at different times of cell conjugates formation (data not shown). Imaging analysis of the formed conjugates showed that p50α and p85α regulatory subunits were differentially recruited to the T-DC contact area depending on the activation state of T cells (Fig. 2D) .
Thus, p50α was recruited exclusively at the IS in activated T cells, whereas p85α was similarly recruited at the IS in resting or activated T cells.
ICOS overexpression brings p50α to the immunological synapse through its YxxM motif.
As shown previously, the p50α regulatory subunit preferentially localizes at the contact zone between an activated T lymphocyte and a dendritic cell (Fig. 2D) , and the ICOS receptor seems to be a good candidate for recruiting the adaptor protein when triggered by its ligand (Fig. 1C ). To further demonstrate the role of ICOS in recruiting p50α at the IS, we analyzed was recruited similarly by both T cell lines (Fig. 3A) . We next investigate the role of the ICOS YxxM intracellular motif in this process, a motif which has previously been shown to recruit p85α (7) . Tyrosine residue 180 in the YMFM motif was mutated to phenylalanine in a Myc-tagged chimeric molecule composed of the extracellular domain of murine CD28 fused to the cytoplasmic domain of human ICOS (Fig. 3B, upper panel) . Localization of this ICOS mutant together with GFP-p50α or GFP-p85α molecules was analyzed after anti-Mycmediated capping. As shown in Fig. 3B , lower panel, the GFP-p50α molecule is distributed throughout the cell before capping. Upon Myc cross-linking, GFP-p50α was substantially recruited at the plasma membrane and identically localized with the ICOS receptor into caps.
Tyrosine mutation into phenylalanine abrogated ICOS and GFP-p50α colocalization at the membrane surface. While ICOS aggregated into caps, GFP-p50α remained diffused in the whole cell. Taken together, these data provide evidence that ICOS expression drives p50α relocalization at the IS via its YxxM motif.
ICOS and p50α localize at the immunological synapse in activated T cells.
We showed that ICOS ligation induced p50α association within the intracellular tail of the receptor (Fig. 1C) , and that ICOS overexpression in Jurkat cells led to increased p50α localization at the IS (Fig. 3A) . As ICOS may have a specific role in recruiting the p50α regulatory subunit to the plasma membrane in activated T cells, we directly investigated ICOS and GFP-p50α localization to the IS between activated CD4+ T cells and dendritic cells. The results showed that p85α was similarly recruited at the contact area when ICOS or CD28 was engaged by its respective ligand. In contrast, ICOS-L was much more efficient than B7.1 in triggering p50α localization at the cell-cell contact (Fig. 4C) . In order to selectively determine the PI3K activity associated to the different regulatory isoforms under ICOS ligation, activated T cells were transfected with GFP, GFP-p50α or GFP-p85α constructs for 24 hrs. Similar level of GFP proteins were detected by flow cytometry (data not shown). T cells were then stimulated with L-LICOS cells for 15 min as previously described.
The PI3K assay was performed on GFP immunoprecipitates (Fig. 4D) . Surprisingly, the GFP protein alone, used as a control, showed a basal PI3K activity. Nevertheless, the PI3K activity associated with both regulatory subunit isoforms (GFP-p50α or GFP-p85α) was higher compared to our control (GFP alone). As previously described for the insulin receptor system in muscle homogenates (21), p50α associated PI3K activity was higher compared to p85α
upon ICOS ligation in activated T cells. Together, these data provide strong evidence that ICOS receptor expression and engagement facilitate p50α localization at the plasma membrane in activated T cells, thus probably leading to the strong PI3K activity associated to the receptor.
ICOS ligation alone, but not CD28, is able to induce a strong phosphorylation of the PI3K effector Akt.
Although little is known about ICOS signaling pathways, it is now clearly established that ICOS is a major PI3K activator associated with strong kinase activity (7, 19) , thus leading to investigate (36) (37) (38) . Previous studies investigating PI3K signaling events and functions mostly focussed on p85α participation. However, there is now growing evidence that differences in the use of regulatory and/or catalytic subunits might occur through costimulatory receptors or adaptor proteins and that PI3K members probably display distinct biological and signaling functions (36) .
ICOS and CD28, both members of the CD28 family of costimulatory receptors, recruit the p85α regulatory subunit, thus leading to PI3K activation and signaling (7, 26) . Expressed following T cell activation, ICOS shows much stronger PI3K activity compared to CD28 (Fig.   1D ), as it is able to produce greatest amounts of PtdInsP 3 leading to strong subsequent phosphorylation of the serine/threonine kinase Akt/PKB, a key PI3K effector (18, 19) . The mechanism of PI3K regulation has been well described in insulin signaling (39) . All studies performed on the PI3K signaling pathway associated with the IRS-1 protein tend to show the same results and confer to the p50α-p110 complex a stronger PI3K activity compared to p55α or p85α regulatory subunits (21) . We postulated that ICOS could be a good candidate in differentially recruiting PI3K regulatory subunits within its intracellular YxxM binding motif and that the p50α regulatory subunit could play an important role in ICOS mediated PI3K activity. Indeed, ICOS associated PI3K signaling pathway seems to be the "key" pathway involved in receptor functions. Consistent with previous studies (17) , pulldown experiments performed with phospho-YxxM peptides, followed by mass spectrometry analysis showed that a unique PI3K signaling pathway is involved in ICOS mediated costimulation. The ICOS intracellular tail exclusively allows functional binding of the regulatory subunit isoforms of class IA PI3K who can in turn, recruit the p110 catalytic subunits (Camille Fos, Stéphane
Audebert, data not shown). We also corroborate data showing that the same YxxM intracellular motif of CD28 is a scaffold for several signaling pathways, as it is able to recruit proteins such as Sos1/2, Cbl, SLP-76, Grb2, and GRID (36) . Unlike CD28 that is constituvely expressed, ICOS can only be detected on the surface of activated T cells (4) (Fig. 1B) . Both p50α and p85α are expressed on resting T cells, but only p85α binds to CD28 upon receptor ligation ( Fig. 1A and 1C) . On activated T cells, ICOS triggering leads to p50α accumulation to the immunological synapse and association with the YMFM motif of the receptor (Fig. 3) .
In contrast to p85α and p55α that are associated with ICOS at a basal state, p50α association with the receptor is an inducible event that occurs following ICOS ligation (Fig. 1C) . Basal association of p85α to the receptor is greatly increased upon ICOS ligation. This basal association of p85α and p55α is also found in CD28 immunoprecipitates and CD28 ligation significantly increases the association of regulatory subunits with the receptor. Surprisingly, ICOS ligation promotes and induces p50α association with CD28 in a way that remains to be explored. However, one can imagine that ICOS brings p50α to the immunological synapse, perhaps in membrane signaling microdomains, and thus provides a p50α reserve to other transmembrane receptors involved in T cell activation (40) (41) (42) . In the same way that CD28
has been shown to enhance and sustain TcR signaling, we can now consider that the ICOS receptor is able to cooperate with CD28 and to strengthen CD28 induced signaling pathways.
A cross-talk between the two CD28 family members may occur at the immunological synapse and needs to be further investigated.
By using different T/APC cell conjugates, we show that ICOS is efficient in bringing p50α to the immunological synapse. By using a T cell model overexpressing ICOS (Fig. 3A) or by triggering ICOS alone with limited contribution of other costimulatory molecules (Fig.   4C ), we show that ICOS plays a critical role in recruiting p50α to the plasma membrane. On T/DC cell conjugates, the participation of ICOS is more difficult to evaluate. When blocking ICOS/ICOS-L (or CD28/CD80) pathway, only a slight but significant decrease is observed in p50α or p85α relocalization to the immunological synapse (Fig. 4B) . Indeed, in this physiological context, several PI3K adaptors and YxxM bearing receptors are involved in recruiting PI3K to the membrane and their relative contribution is difficult to evaluate. siRNA directed to p50α or p85α were designed in order to selectively extinguished these regulatory subunits and to investigate their role in ICOS mediated PI3K signaling and effector functions.
Unfortunately, we were not able to downregulate PI3K gene expression in human T cells or in other T cell lines. p85α and p50α expression remained the same in all analysed conditions. Furthermore, when a downregulation was observed in heterologous cell lines, both regulatory subunits were touched in a non selective way (data not shown). Knock-out mice models of pik3r genes showed that class IA PI3K regulatory subunits are important for T cell functions (35, 38) . Great efforts have been made to better understand the participation of each regulatory subunit but there is real difficulty in evaluating the relative contribution of each subunit because of compensatory effects between class IA members. Since we show that p50α
accumulates to the IS in activated T cells only, the phenotype of pik3r knock-out mice should be reevaluated in secondary responses when receptors susceptible to associate with p50α are expressed. Indeed, maintenance of T cell longevity has been shown to involve OX40 costimulation-regulated duration of Akt activation (43) . Like OX40 that is induced following T cell activation, ICOS ligation provides a strong activation signal for the serine/threonine kinase Akt (Fig. 5) , which can in turn regulate antiapoptotic molecules such as GSK-3.
Following T cell activation, the PI3K/Akt/GSK-3 pathway might thus be involved in IL-10 production by ICOS expressing cells. Indeed, previous data showed that Akt mediated GSK3
inactivation promotes a great increase in IL-10 production following Toll-like receptor ligation (44) . In contrast to CD28 that predominantly acts during the primary response, ICOS 
